The T-cell antigen CD5 acts as a receptor and substrate for the protein-tyrosine kinase p56lck.

Por Raab, M, Yamamoto, M, Rudd, C E
Publicado em 1994

Targeting the Pim kinases in multiple myeloma

Por Keane, N A, Reidy, M, Natoni, A, Raab, M S, O'Dwyer, M
Publicado no Blood Cancer J (2015)

p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications...

Por Raab, M, Cai, Y C, Bunnell, S C, Heyeck, S D, Berg, L J, Rudd, C E
Publicado em 1995

Src-homology 3 domain of protein kinase p59fyn mediates binding to phosphatidylinositol 3-kinase in T cells.

Por Prasad, K V, Janssen, O, Kapeller, R, Raab, M, Cantley, L C, Rudd, C E
Publicado em 1993

Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index

Por Dempfle, A, Hinney, A, Heinzel-Gutenbrun..., M, Raab, M, Geller, F, Gudermann, T, Schafer, H, Hebebrand, J
Publicado em 2004

T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif.

Por Prasad, K V, Cai, Y C, Raab, M, Duckworth, B, Cantley, L, Shoelson, S E, Rudd, C E
Publicado em 1994

Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation

Por Xu, J, Pfarr, N, Endris, V, Mai, E K, Md Hanafiah, N H, Lehners, N, Penzel, R, Weichert, W, Ho, A D, Schirmacher, P, Goldschmidt, H, Andrulis, M, Raab, M S
Publicado no Oncogenesis (2017)

E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271

Por Natoni, A, Smith, T A G, Keane, N, McEllistrim, C, Connolly, C, Jha, A, Andrulis, M, Ellert, E, Raab, M S, Glavey, S V, Kirkham-McCarthy, L, Kumar, S K, Locatelli-Hoops, S C, Oliva, I, Fogler, W E, Magnani, J L, O'Dwyer, M E
Publicado no Leukemia (2017)